In fact, ADRB2 is significantly upregulated in these genetically engineered pancreatic cancer mouse models, thereby increasing NGF and BDNF production, stimulating NGF/Trk pathways and enhancing pancreatic nerve density [72]. Here, NTRK1 is linked to pancreatic neoplasm.